We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An artificial intelligence (AI) platform that evaluated early signs of infection in hospitalized patients reduced death from sepsis by more than 18 percent, according to researchers at Johns Hopkins University. Read More
Florida-based drug developer Transpire Bio has teamed up with Sweden’s Recipharm to develop inhaled medicines for treating asthma and chronic obstructive pulmonary disease (COPD). Read More
Xeljanz, a Janus Kinase Inhibitor, is FDA-approved for several indications, including for patients with moderate-to-severe active ulcerative colitis. Read More
Remidio, an India-based medical device company that develops eye testing technology using AI and telemedicine integrated devices, announced clinical trial results showing that its Medios Al algorithm can help detect patients with “referable” glaucoma. Read More
NeuroEM Therapeutics announced that its MemorEM medical device has shown the ability to “re-balance” the immune system in Alzheimer’s Disease patients enrolled in a clinical trial. Read More
Masimo announced results from a two-part study showing that its SafetyNet monitoring system can help COVID-19 patients decrease their length of hospital stay. Read More
Canadian diagnostics company Nanostics released interim trial data showing its ClarityDX prostate test is 147 percent more specific than the prostate-specific antigen (PSA) blood test for predicting clinically significant prostate cancer. Read More
A new study evaluating Cardiologs’ deep learning tool for identifying patients at risk for atrial fibrillation (AFib) showed that it outperformed regular 12-lead electrocardiogram (ECG) testing. Read More
Miami, Fla.-based DermaSensor said two studies of its handheld skin cancer detection device — which could become the first FDA-cleared device of its kind for use by primary care physicians — have demonstrated the device’s efficacy. Read More
The FDA has just published the agency’s latest update to its Recognized Consensus Standard Database that device sponsors can cite in their device submissions. Read More
An early feasibility study is finding that hydrogel injected into lumbar spinal discs is safe while substantially relieving chronic low back pain caused by degenerative disc disease (DDD). Read More